Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Abstract Background Chronic kidney disease (CKD) patients face the risk of rapid kidney function decline leading to adverse outcomes like dialysis and mortality. Lipid metabolism might contribute to acute kidney function decline in CKD patients. Here, we utilized the Mendelian Randomization approach...
Saved in:
Main Authors: | Zhicheng Zhao (Author), Yu Wan (Author), Han Fu (Author), Shuo Ying (Author), Peng Zhang (Author), Haoyu Meng (Author), Yu Song (Author), Naikuan Fu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study
by: Yu Min, et al.
Published: (2023) -
Association of urinary fatty acid-binding protein 1 with a rapid decline of renal function in elders with type 2 diabetes mellitus
by: Yu Wang, et al.
Published: (2024) -
Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
by: Tong Wu, et al.
Published: (2023) -
Causal relationship between affect disorders and endometrial cancer: a Mendelian randomisation study
by: Yewu Sun, et al.
Published: (2024) -
Identification of molecular mediators of renal sarcopenia risk: a mendelian randomization analysis
by: Peng Yan, et al.
Published: (2024)